PALMIYE ILAC KIMYA VE GIDA SANAYI TICARET ANONIM SIRKETI – Trademark Portfolio
Entity Type: 99
PALMIYE ILAC KIMYA VE GIDA SANAYI TICARET ANONIM SIRKETI holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include DR. THOMSON JONES. The owner is based in Kartal, Istanbul.
Orta Mahalle Ordu Sokak Iz Park Plaza C
Kartal, Istanbul 34862 , TR
Showing of trademarks Trademarks
Trademark Classifications
PALMIYE ILAC KIMYA VE GIDA SANAYI TICARET ANONIM SIRKETI's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does PALMIYE ILAC KIMYA VE GIDA SANAYI TICARET ANONIM SIRKETI have?
PALMIYE ILAC KIMYA VE GIDA SANAYI TICARET ANONIM SIRKETI has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does PALMIYE ILAC KIMYA VE GIDA SANAYI TICARET ANONIM SIRKETI file in?
PALMIYE ILAC KIMYA VE GIDA SANAYI TICARET ANONIM SIRKETI files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are PALMIYE ILAC KIMYA VE GIDA SANAYI TICARET ANONIM SIRKETI's most well-known trademarks?
PALMIYE ILAC KIMYA VE GIDA SANAYI TICARET ANONIM SIRKETI's registered trademark portfolio includes well-known marks such as DR. THOMSON JONES. These are among 1 currently registered trademark in the portfolio.
What is PALMIYE ILAC KIMYA VE GIDA SANAYI TICARET ANONIM SIRKETI's trademark registration success rate?
PALMIYE ILAC KIMYA VE GIDA SANAYI TICARET ANONIM SIRKETI has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.